Scholarlink

Background and aim <p>Previous research described a catalyst-free, post-Ugi synthesis of two distinct series of highly substituted fused pyrazolo-pyrazines. One of these series demonstrated antitumor activity against colorectal cancer (CRC) cells. However, the precise mechanistic pathways remain poorly understood, particularly with respect to effects on autophagy regulation, DNA repair processes, and death-receptor-mediated extrinsic apoptosis.</p> Methods <p>The cytotoxic properties of compound 7&#xa0;h were assessed through MTT and colony formation assays, while apoptosis was evaluated by flow cytometry and western blotting. Immunofluorescence, GFP-LC3 transfection and mCherry-GFP-LC3B transfection were performed to assess autophagic activity. Synergistic interactions between derivative 7&#xa0;h and 5-fluorouracil (5-FU) were investigated to assess enhanced CRC chemosensitivity. Molecular docking simulations were conducted to predict the binding conformation of compound 7&#xa0;h with its molecular target and to identify potential interaction sites contributing to its inhibitory activity.</p> Results <p>Compound 7&#xa0;h exhibited significant cytotoxic effects, inhibiting the proliferation and growth of CRC cells in vitro. Mechanistic investigations demonstrated that the cytotoxic activity of compound 7&#xa0;h was mediated by impeding autophagic flux, thereby inducing DNA damage, inhibiting DNA repair, and ultimately promoting death receptor (DR)-mediated extrinsic apoptosis in CRC cells. Furthermore, the combination of compound 7&#xa0;h with 5-FU exhibited synergistic inhibition of CRC cell proliferation, suggesting that compound 7&#xa0;h could enhance CRC sensitivity to 5-FU.</p> Conclusions <p>Our results suggest that impaired autophagic flux progression following treatment with compound 7&#xa0;h leads to DNA damage and death-receptor-mediated apoptosis, underscoring the potential of compound 7&#xa0;h as a novel therapeutic approach for CRC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Compound 7 h exerts its anti-oncogenic effects on colorectal cancer cells by inducing death-receptor-mediated apoptosis, promoting DNA damage, and obstructing autophagic flux

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月20日

查看全文
  • Donglin Yang,
  • Yanlai Fu,
  • Jiuhong Huang,
  • Tianzhi Zhang,
  • Hongyi Nie,
  • Yajun Zhang

摘要

Background and aim

Previous research described a catalyst-free, post-Ugi synthesis of two distinct series of highly substituted fused pyrazolo-pyrazines. One of these series demonstrated antitumor activity against colorectal cancer (CRC) cells. However, the precise mechanistic pathways remain poorly understood, particularly with respect to effects on autophagy regulation, DNA repair processes, and death-receptor-mediated extrinsic apoptosis.

Methods

The cytotoxic properties of compound 7 h were assessed through MTT and colony formation assays, while apoptosis was evaluated by flow cytometry and western blotting. Immunofluorescence, GFP-LC3 transfection and mCherry-GFP-LC3B transfection were performed to assess autophagic activity. Synergistic interactions between derivative 7 h and 5-fluorouracil (5-FU) were investigated to assess enhanced CRC chemosensitivity. Molecular docking simulations were conducted to predict the binding conformation of compound 7 h with its molecular target and to identify potential interaction sites contributing to its inhibitory activity.

Results

Compound 7 h exhibited significant cytotoxic effects, inhibiting the proliferation and growth of CRC cells in vitro. Mechanistic investigations demonstrated that the cytotoxic activity of compound 7 h was mediated by impeding autophagic flux, thereby inducing DNA damage, inhibiting DNA repair, and ultimately promoting death receptor (DR)-mediated extrinsic apoptosis in CRC cells. Furthermore, the combination of compound 7 h with 5-FU exhibited synergistic inhibition of CRC cell proliferation, suggesting that compound 7 h could enhance CRC sensitivity to 5-FU.

Conclusions

Our results suggest that impaired autophagic flux progression following treatment with compound 7 h leads to DNA damage and death-receptor-mediated apoptosis, underscoring the potential of compound 7 h as a novel therapeutic approach for CRC.